Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sublingual hyposensitization].

J L Halloy1

  • 1Service de Pneumologie, CHR Saint Joseph--Hôpital de Warquignies, Boussu.

Revue Medicale De Bruxelles
|November 2, 2004
PubMed
Summary
This summary is machine-generated.

Specific immunotherapy is the only effective treatment for allergic diseases. Sublingual immunotherapy offers a safer, more convenient alternative to subcutaneous injections, with comparable results and WHO recognition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between sensitization to natural rubber latex and papain.

The Journal of allergy and clinical immunology·1996
Same author

[Diagnosis and evaluation of lung cancer. Development during 1973-1982].

Revue medicale de Bruxelles·1986
Same author

[Bronchial asthma (author's transl)].

Revue medicale de Bruxelles·1981
Same author

Changes in regional and overall lung function after bronchography.

European journal of nuclear medicine·1980
Same author

[Regional lung function in coal workers (author's transl)].

Bulletin europeen de physiopathologie respiratoire·1978

Area of Science:

  • Immunology
  • Allergology

Context:

  • Allergic diseases require disease-modifying treatments.
  • Advances in immunology enhance understanding of treatment mechanisms.
  • Purified and standardized allergen solutions improve treatment outcomes.

Purpose:

  • To review the efficacy of specific immunotherapy for allergic diseases.
  • To compare subcutaneous immunotherapy (SCIT) with sublingual immunotherapy (SLIT).

Summary:

  • Specific immunotherapy is the sole method for profoundly altering allergic disease progression.
  • Subcutaneous immunotherapy is the established standard, but sublingual immunotherapy has emerged as a viable alternative.
  • Sublingual immunotherapy, favored for its safety and convenience, allows earlier treatment initiation and higher dosage, yielding results comparable to SCIT.

Related Experiment Videos

Impact:

  • Sublingual immunotherapy is increasingly recognized as a full treatment for certain allergic conditions.
  • This shift offers improved patient compliance and earlier intervention possibilities.
  • The findings support wider adoption of SLIT in clinical practice for allergic disease management.